Shares of Indivior PLC (LON:INDV – Get Free Report) traded up 11.1% on Friday . The stock traded as high as GBX 799 ($10.66) and last traded at GBX 772 ($10.30). 551,238 shares were traded during mid-day trading, a decline of 49% from the average session volume of 1,087,031 shares. The stock had previously closed at GBX 695 ($9.27).
Indivior Stock Up 2.1 %
The stock has a market cap of £1.23 billion, a P/E ratio of -653.37, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The stock’s 50-day moving average is GBX 723.43 and its 200-day moving average is GBX 802.80.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
See Also
- Five stocks we like better than Indivior
- What is MarketRank™? How to Use it
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Why Smart Investors Don’t Panic in Election Season
- Comparing and Trading High PE Ratio Stocks
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.